512529 — Sequent Scientific Share Price
0.000.00%
Last trade - 00:00- IN₹37.03bn
- IN₹41.85bn
- IN₹13.70bn
- 90
- 10
- 61
- 56
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 5.45 | ||
| Price to Tang. Book | 9.84 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.45 | ||
| EV to EBITDA | 30.28 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.65% | ||
| Return on Equity | 1.78% | ||
| Operating Margin | 4.72% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 11,792.44 | 13,616.15 | 14,128.16 | 14,209.09 | 13,697.31 | n/a | n/a | 5.68% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +44.05 | +44.12 | -59.77 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
SeQuent Scientific Limited is an India-based animal health company. The Company provides a wide range of animal health products, including finished dose formulations, active pharmaceutical ingredients (APIs), as well as analytical services. The Company operates through the pharmaceuticals segment. The Company is focused on various therapies, such as targeted are anthelmintics (endo and ecto parasiticides), anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infectives and dermatology. It is specialized in analytical and bio analytical services to support the API, pharmaceutical, personal care and nutraceutical companies. It provides analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopoeia monographs, customer developed methods or in-house method development. The Company’s subsidiaries include Alivira Animal Health Limited and SeQuent Research Limited.
Directors
- Manish Gupta CEO
- Tushar Mistry CFO
- Krunal Shah CCO
- Gautam Das MDR (57)
- Neeraj Bharadwaj NED
- Fabian Kausche NED
- Rahul Mukim NED
- Milind Sarwate NED (62)
- Kamal Sharma NED
- Gregory Andrews NID
- Kausalya Santhanam NID
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 28th, 1985
- Public Since
- March 10th, 2016
- No. of Shareholders
- 169,737
- No. of Employees
- 1,195
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 249,889,745
- Address
- 301/A, 3rd Floor,, MUMBAI, 400604
- Web
- https://sequent.in/
- Phone
- +91 2241114777
- Contact
- Phillip Trott
- Auditors
- S R B C & CO LLP
Upcoming Events for 512529
Q1 2026 SeQuent Scientific Ltd Earnings Release
SeQuent Scientific Ltd Annual Shareholders Meeting
Similar to 512529
Aayush Wellness
Bombay Stock Exchange
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
FAQ
What is the Sequent Scientific share price?
As of Today at 23:09 UTC, shares in Sequent Scientific are trading at IN₹147.95. This share price information is delayed by 15 minutes.
How has the Sequent Scientific share price performed this year?
Shares in Sequent Scientific last closed at IN₹147.95 and the price had moved by +24.07% over the past 365 days. In terms of relative price strength the Sequent Scientific share price has outperformed the S&P BSE 100 Index by +14.95% over the past year.
What are the analyst and broker recommendations for Sequent Scientific?
The overall consensus recommendation for Sequent Scientific is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Sequent Scientific dividend yield?
Sequent Scientific does not currently pay a dividend.
Does Sequent Scientific pay a dividend?
Sequent Scientific does not currently pay a dividend.
When does Sequent Scientific next pay dividends?
Sequent Scientific does not currently pay a dividend.
How do I buy Sequent Scientific shares?
To buy shares in Sequent Scientific you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Sequent Scientific?
As of the previous close price of IN₹147.95, shares in Sequent Scientific had a market capitalisation of IN₹37.03bn.
Where are Sequent Scientific shares listed?
Here are the trading details for Sequent Scientific:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 512529
What kind of share is Sequent Scientific?
Based on an overall assessment of its quality, value and momentum Sequent Scientific is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Sequent Scientific share price forecast for 2025?
The analyst consensus target price for shares in Sequent Scientific is IN₹133.50. That is 9.77% below the last closing price of IN₹147.95.
Analysts covering Sequent Scientific currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the Sequent Scientific share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sequent Scientific. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -13.94%.
As of the last closing price of IN₹147.95, shares in Sequent Scientific were trading -11.75% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Sequent Scientific PE Ratio?
The Sequent Scientific PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹147.95.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Sequent Scientific?
Sequent Scientific's management team is headed by:
- Manish Gupta - CEO
- Tushar Mistry - CFO
- Krunal Shah - CCO
- Gautam Das - MDR
- Neeraj Bharadwaj - NED
- Fabian Kausche - NED
- Rahul Mukim - NED
- Milind Sarwate - NED
- Kamal Sharma - NED
- Gregory Andrews - NID
- Kausalya Santhanam - NID